Clinical Trials Browser

Phase 1/2 × Simpson-Golabi-Behmel syndrome × Immunotherapy, Adoptive × Clear all

NCT02723942 2020-07-16

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Phase 1/2 Withdrawn

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Carcinoma, Hepatocellular